Live
- Man reported dead after self immolation near court during ex-US Prez Trump's trial
- Mahabubabad: KCR cut a deal with Modi to save Kavitha says Revanth
- 3 hurdles teachers face & how to overcome them
- IIT Roorkee team finds giant ancient snake fossil
- Delhi Rouse Avenue Court reserves verdict on Manish Sisodia's Bail Petition
- TDP MP Kanakamedala Ravindra writes to ECI, briefs current situation in AP
- Boat Capsizes in Mahanadi River in Odisha, 7 Dead
- iOS 18 Update to Introduce Powerful AI Features to iPhone
- YS Sharmila Reddy files nomination as Congress MP candidate in Kadapa district
- Karimnagar: Candidates of major parties file nominations
Hyderabad: Envoys of 80 countries to visit covid vaccine centre at Bharat Biotech today
Envoys of 80 countries to visit covid vaccine centre at Bharat Biotech today
Ambassadors and high commissioners of around 80 foreign countries to visit COVID-19 vaccine centre at Bharat Biotech and BE limited today.
Ambassadors and high commissioners of around 80 foreign countries to visit COVID-19 vaccine centre at Bharat Biotech and BE limited today. The visit is organised by the Ministry of External Affairs. The one-day visit of the foreign dignitaries has been planned to familiarise them with vaccine preparation, production opportunities and the vaccine distribution plan.
The team will arrive in Hyderabad at 10 am today. State Chief Secretary Somesh Kumar along with Chief of Protocol Nagesh Singh and other senior officials has already made arrangements for the foreign team's visit to Hyderabad. The CS directed the authorities to provide well-equipped buses, a special medical team. "A presentation should also be made to showcase the state's potential in the production and supply of vaccine and should also include the Pharma City and Genome Valley," according to the official release.
Last week, Prime Minister Narendra Modi visited the Bharat Biotech vaccine centre to review the developmental work on the coronavirus vaccine.
At present, the Covaxin developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) is under Phase-III of clinical trials. The human trials of the vaccine are being conducted at Nizam's Institute of Medical Sciences (ICMR).
